University Lecture – Heyo K. Kroemer/Charité
"The Future of Medicine" was discussed by Heyo K. Kroemer, Chairman of the Board of Charité - Universitätsmedizin Berlin, in the University Lecture on the Day of the Medical University of Vienna 2024.
Heyo K. Kroemer, born in Leer in Germany in 1960, studied pharmacy at the Technical University of Braunschweig. After study and research stays in Basel and Nashville, he habilitated in pharmacology and toxicology in Tübingen in 1992. From 2000 to 2012, he was Dean of the Faculty of Medicine at the University of Greifswald and, from 2011, also Scientific Director of Greifswald University Medicine. From 2012 to 2019, he was full-time Dean of the University Medical Centre Göttingen and President of the Medical Faculty Association. Kroemer is also a member of the Leopoldina, the board of the Association of German University Hospitals, the Berlin-Brandenburg Academy of Sciences and Humanities and the German Academy of Science and Engineering. Kroemer has represented Charité in all matters as Chairman of the Executive Board since 2019. He is responsible for corporate development and ensures the integration of the various corporate objectives and the balance of interests between clinical and scientific requirements.
Anniversary Lecture - Christoph Huber
Christoph Huber, member of MedUni Vienna's University Council and vaccination pioneer, gave the anniversary lecture on "The joys and sorrows of research transfer".
Christoph Huber is a haematologist, immunologist and oncologist and sits on numerous boards and committees. He established a stem cell transplantation and immunotherapy programme in Innsbruck and a leading international centre for immuno-oncology and stem cell transplantation in Mainz. In 2001, together with Uğur Şahin and Özlem Türeci, he founded Ganymed, which develops monoclonal antibodies against tumour antigens; in 2008 he established BioNTech, which researches genetically modified defence cells, mRNA-encoded antibodies and mRNA vaccines, among others, and produced the first approved Covid-19 vaccine and in 2010 he set up the not-for-profit translational oncology institute TRON.